Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Centre of Excellence for Precision Medicine in Pediatric Care

Project description

Paediatric care with precision medicine

While precision medicine has transformed adult healthcare by tailoring treatments to individual needs, its potential in paediatric care remains untapped. The EU-funded PMPC project aims to bridge this gap by establishing a cutting-edge Centre of Excellence (CoE) for precision medicine at the Children’s Clinical University Hospital (CCUH) in Latvia. In collaboration with the Princess Maxima Center in the Netherlands, the CoE will integrate research, innovation, care and education to advance paediatric treatments. Leveraging expertise in genomics, cell therapies and computational biology, this initiative aims to deliver better outcomes for young patients. Overall, PMPC is poised to position CCUH as a leader in paediatric precision medicine research and care in Europe.

Objective

The vision of the PMPC (“Centre of excellence for precision medicine in pediatric care”) project is to position the Children’s Clinical University Hospital (CCUH) in Latvia at the leading-edge of pediatric precision medicine research and care in Europe. Precision medicine has proven its potential to revolutionize healthcare by tailoring treatments to individual patients based on their unique genetic makeup, environment and lifestyle factors. While it has shown promise and delivers results in adult populations, its potential in pediatric care is largely untapped.
Our goal is to improve pediatric patient care and outcomes by establishing a new research Centre of Excellence (CoE) at CCUH’s campus for research on and adoption of innovative precision medicine approaches in an integrated and collaborative RESEARCH +INNOVATION+CARE+EDUCATION (“R+I+C+E”) environment. To this end, CCUH will team-up with Europe’s leading institute in pediatric precision medicine: the Princess Maxima Center, The Netherlands. Maxima has an extensive precision medicine program and uses advanced translational research and treatment expertise in many areas, including CAR-T cell therapies and pediatric clinical trials. The CoE will provide an environment for transdisciplinary team science with international visibility in the field of pediatric precision medicine. The center will leverage the latest advances in genomics, cell therapies, data science, and computational biology.
CCUH has secured 20 million EUR from private donors as a complementary part of funding. Together with the Horizon Europe grant, the valuable knowledge/technology transfer and active collaboration with the Maxima team, PMPC’s unique value will be brought forward resulting in benefits for patients, their caregivers, researchers, healthcare professionals and society. It will strengthen CCUH’s scientific and technological capacity in precision medicine, enabling it to attain a competitive position in this promising field.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-WIDERA-2023-ACCESS-01

See all projects funded under this call

Coordinator

BERNU KLINISKA UNIVERSITATES SLIMNICA VALSTS SIA
Net EU contribution
€ 9 680 125,00
Address
VIENIBAS GATVE 45
1004 Riga
Latvia
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 9 680 125,00

Participants (1)